Anderson–Fabry Disease: From Endothelial Dysfunction to Emerging Therapies

<div>Pathophysiology and clinical correlates of Anderson–Fabry disease. The ubiquitous accumulation of GL-3 is central to disease onset and progression.</div>

Advances in Pharmacological and Pharmaceutical Sciences

fig1

Figure 1

Figure 1: Anderson–Fabry Disease: From Endothelial Dysfunction to Emerging Therapies 